Federal Register / Vol. 75, No. 23 / Thursday, February 4, 2010 / Notices 5767 

requesting exporter accounts for a 

significant proportion of exports of the 

subject merchandise, and (3) no 

compelling reasons for denial exist, we 

are granting the request and are 

postponing the final determination until 

no later than 135 days after the 

publication of the preliminary 

determination notice in the Federal 

Register, or May 21, 2010. Further, in 

accordance with section 733(d) of the 

Act, suspension of liquidation will be 

extended accordingly. This 

postponement is issued and published 

in accordance with19 CFR 351.210(g). 

Dated: January 28, 2010. 

Ronald K. Lorentzen, 

Deputy Assistant Secretary for Import 

Administration. 

[FR Doc. 2010–2316 Filed 2–3–10; 8:45 am] 

BILLING CODE 3510–DS–S 

CONSUMER PRODUCT SAFETY 

COMMISSION 

All Terrain Vehicle Chinese Language 

Webinar; Meeting 

AGENCY: Consumer Product Safety 

Commission. 

ACTION: Notice. 

The Consumer Product Safety 

Commission (CPSC) is announcing the 

following meeting: All Terrain Vehicle 

Chinese Language Webinar. The 

webinar will focus on CPSC’s 

requirements for ATV’s, including 

CPSC’s Action Plan and mandatory 

vehicle requirements. 

Date and Time: The meeting will be 

held on February 4, 2010 at 6:00 am 

Eastern Standard Time. 

Location: The meeting will be held 

live via webinar. Chinese language 

speakers can access the webinar at 

http://www.cpsc.gov/webcast/ 

index_ch.html. English speakers can 

access the webinar at http:// 

www.cpsc.gov/webcast/index.html. 

Contact: Laurie Hopkins, 

International Programs Coordinator, 

Office of International Programs and 

Intergovernmental Affairs, Consumer 

Product Safety Commission, 4330 East 

West Highway, Suite 505–A, 301–504– 

7797, FAX: 301–504–0137 e-mail: 

lhopkins@cpsc.gov. 

Dated January 26, 2010. 

Todd A. Stevenson, 

Secretary of the Commission. 

[FR Doc. 2010–2072 Filed 2–3–10; 8:45 am] 

BILLING CODE 6355–01–M 

CONSUMER PRODUCT SAFETY 

COMMISSION 

Sunshine Act Meetings 

TIME AND DATE: Wednesday, February 3, 

2010, 2 p.m.–4 p.m. 

PLACE: Hearing Room 420, Bethesda 

Towers, 4330 East West Highway, 

Bethesda, Maryland. 

STATUS: Closed to the public. 

MATTER TO BE CONSIDERED: Compliance 

Weekly Report—Commission Briefing. 

The staff will brief the Commission on 

various compliance matters. 

For a recorded message containing the 

latest agenda information, call (301) 

504–7948. 

CONTACT PERSON FOR MORE INFORMATION: 

Todd A. Stevenson, Office of the 

Secretary, U.S. Consumer Product 

Safety Commission, 4330 East West 

Highway, Bethesda, MD 20814 (301) 

504–7923. 

Dated January 26, 2010. 

Todd A. Stevenson, 

Secretary. 

[FR Doc. 2010–2068 Filed 2–3–10; 8:45 am] 

BILLING CODE 6355–01–M 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Veterans’ Advisory Board on Dose 

Reconstruction; Meeting 

AGENCY: Defense Threat Reduction 

Agency, DoD. 

ACTION: Advisory board meeting notice. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix, as amended) 

and the Sunshine in the Government 

Act of 1976 (5 U.S.C. 552b, as amended) 

the Defense Threat Reduction Agency 

(DTRA) and the Department of Veterans 

Affairs (VA) announce the following 

advisory board meeting of the Veterans’ 

Advisory Board on Dose Reconstruction 

(VBDR). The public is invited to attend. 

DATES: The meeting will be held on 

Thursday, March 4, 2010, from 8:30 a.m. 

to 11:45 a.m. and from 1:15 p.m. to 5 

p.m. A public comment session is 

scheduled from 10:15 a.m. to 10:45 a.m. 

ADDRESSES: The meeting will be held at 

the Hilton Arlington Hotel, 950 North 

Stafford Street, Arlington, VA 22203. 

FOR FURTHER INFORMATION CONTACT: The 

Veterans’ Advisory Board on Dose 

Reconstruction Toll Free at 1–866–657– 

VBDR (8237). 

Additional information may be found 

at http://vbdr.org. 

SUPPLEMENTARY INFORMATION: 

Purpose of Meeting 

To obtain, review and evaluate 

information related to the Board’s 

mission to provide guidance and 

oversight of the dose reconstruction and 

claims compensation programs for 

veterans of U.S.-sponsored atmospheric 

nuclear weapons tests from 1945–1962; 

veterans of the 1945–1946 occupation of 

Hiroshima and Nagasaki, Japan; and 

veterans who were prisoners of war in 

those regions at the conclusion of World 

War II. In addition, the advisory board 

will assist the VA and DTRA in 

communicating with the veterans. 

Meeting Agenda 

The meeting will open with an 

introduction of the Board. After 

introductions, the following briefings 

will be presented: ‘‘Veterans Health 

Administration Procedures and the 

Ionizing Radiation Registry’’ by Victoria 

Cassano, M.D.; ‘‘Discussion on: 

Projecting Future Operations of VBDR at 

the Strategic Level (September 15, 2009 

Draft)’’ by Dr. John Lathrop; ‘‘Update on 

the NTPR Dose Reconstruction Program’’ 

by Dr. Paul Blake; and ‘‘Update on the 

VA Radiation Claims Compensation 

Program for Veterans’’ by Mr. Brad 

Flohr. The morning session includes 

one half-hour open public comment 

session. In the afternoon, the four 

subcommittees established during the 

inaugural VBDR session will report on 

their activities since June 2009. The 

subcommittees are the ‘‘Subcommittee 

on DTRA Dose Reconstruction 

Procedures,’’ the ‘‘Subcommittee on VA 

Claims Adjudication Procedures,’’ the 

‘‘Subcommittee on Quality Management 

and VA Process Integration with DTRA 

Nuclear Test Personnel Review 

Program,’’ and the ‘‘Subcommittee on 

Communication and Outreach.’’ The 

remainder of the meeting will be 

devoted to a discussion of the future of 

the VBDR. 

Meeting Accessibility 

Pursuant to 5 U.S.C. 552b, as 

amended, and 41 CFR 102–3.140 

through 102–3.165, and the availability 

of space, this meeting is open to the 

public. Seating is limited by the size of 

the meeting room. All persons must sign 

in legibly at the registration desk. 

Written Statements 

Pursuant to 41 CFR 102–3.105(j) and 

102–3.140(c), interested persons may 

submit a written statement for 

consideration by the Veterans’ Advisory 

Board on Dose Reconstruction. Written 

statements should be no longer than two 

type written pages and must address: 

The issue, discussion, and 

recommended course of action. 


srobinson on DSKHWCL6B1PROD with NOTICES